EN UNA EMPRESA EN LA QUE HAY CABILDER@S , ONCOLOG@S , CIENTÍFIC@S , GURUS , ANALISTAS , FONDOS ... CON CONFLICTO DE INTERES ... SIEMPRE HABRA UN DISCURSO ÚNICO ...
16 abril 2008
PharmaMar Farmaco Preclinico con actividad en Cancer de Pulmon y Colon .
Cytotoxic-Antineoplastic Derivatives of Prenyl-1,2-naphthohydroquinone
Abstract
Several new prenyl-1,2-naphthohydroquinone derivatives have been prepared by chemical modifications of Diels-Alder products which were obtained from cycloaddition of -myrcene to 1,2-benzoquinone and then evaluated in vitro for their cytotoxic activity against A-549 lung carcinoma, HT-29 colon carcinoma, and MB-231 breast adeno-carcinoma culture cells. Most of them exhibited GI50 values in the M-concentration level.
Abstract
Several new prenyl-1,2-naphthohydroquinone derivatives have been prepared by chemical modifications of Diels-Alder products which were obtained from cycloaddition of -myrcene to 1,2-benzoquinone and then evaluated in vitro for their cytotoxic activity against A-549 lung carcinoma, HT-29 colon carcinoma, and MB-231 breast adeno-carcinoma culture cells. Most of them exhibited GI50 values in the M-concentration level.
Suscribirse a:
Entradas (Atom)